Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Starpharma's DNT Priostar(TM) Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents

Abstract:
Starpharma (ASX:SPL, OTCQX: SPHRY), through its US subsidiary company Dendritic
Nanotechnologies Inc (DNT), has found that DNT's Priostar(TM) dendrimer
technology can be used to amplify the signal and increase the duration of
the signal (photostability) of existing products in the multi-billion
dollar fluorescent reagents market. The company has filed a patent for the
discovery through DNT.

Starpharma's DNT Priostar(TM) Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents

MELBOURNE, Australia | Posted on May 7th, 2007

Fluorescent reagents are used extensively in laboratories for high-
throughput screening, diagnostic immunoassays, microarrays, fluorescence
microscopy, genomics and proteomics. Strong signals and photostability are
extremely important properties as they increase the sensitivity of
detection methods and facilitate measurement of the signal, respectively.

Increased sensitivity is needed to study disease markers that are
present at very low levels -- often below those detectable with current
technologies.

Using its Priostar(TM) technology, DNT has created dye-dendrimer
complexes from various commercial dyes that show significantly enhanced
fluorescent (greater than 10 fold) and photostability (greater than 4
fold), in addition to improved solubility in water.

Preliminary testing has shown that the enhanced properties of
Priostar(TM) dendrimer-dye complexes are retained after attachment to an
antibody, an integral component for many of the applications of fluorescent
dyes.

"Market feedback indicates that the scientific community and industry
users of these products will highly value the availability of reagents with
increased sensitivity and photostability," said Dr. Lori Reyna, director of
life sciences at DNT. Scientists are always keen to increase the
sensitivity of detection and quantitation methods."

DNT will partner with established leaders in the diagnostic and
research reagent industries through licensing and supply agreements. The
initial commercialization target will be the research reagent and in vitro
diagnostic markets. DNT is currently in preliminary commercialization
discussions with the market leaders in the area of fluorescence reagents.

####

About Starpharma
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world leader in
the development of dendrimer nanotechnology for pharmaceutical,
life-science and other applications. SPL is principally composed of two
operating companies, Starpharma Pty Ltd in Melbourne, Australia and
Dendritic Nanotechnologies, Inc in Michigan, USA.

For more information, please click here

Contacts:
Media:
Rebecca Wilson
Buchan Consulting
Tel: +61 2 9237 2800
Mob: +61 417 382 391


Starpharma:
Dr Jackie Fairley
Chief Executive Officer Starpharma Holdings Ltd
+61 3 8532 2704

Dr Robert Berry
President
DNT
Tel: 989.774.1799


Ben Rogers
Company Secretary
Starpharma Holdings Ltd
+61 3 8532 2702


Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

Carnegie Mellon chemists characterize 3-D macroporous hydrogels: Methods will allow researchers to develop new 'smart' materials June 30th, 2015

Chitosan coated, chemotherapy packed nanoparticles may target cancer stem cells June 30th, 2015

Researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th, 2015

Announcements

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

Bruker Introduces Second-Generation Inspire Nanochemical Imaging Solution: Featuring Unique PeakForce IR and IR EasyAlign Technology July 1st, 2015

GLOBALFOUNDRIES Completes Acquisition of IBM Microelectronics Business: Transaction adds differentiating technologies, world-class technologists, and intellectual property July 1st, 2015

Samsung's New Graphene Technology Will Double Life Of Your Lithium-Ion Battery July 1st, 2015

Nanobiotechnology

Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015

Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015

Researchers first to show that Saharan silver ants can control electromagnetic waves over an extremely broad range of the electromagnetic spectrum—findings may lead to biologically inspired coatings for passive radiative cooling of objects June 19th, 2015

Cellulose from wood can be printed in 3-D June 17th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project